Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.28 Analyst target: $1.03 Upside: 268.67%
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.
See the full interactive analysis & chart →Informational only — not investment advice.